[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Natural Killer (NK) Cell Therapeutics Market Report 2019

September 2019 | 121 pages | ID: G051F90C56FEN
BisReport Information Consulting CO., Ltd

US$ 2,350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
With the slowdown in world economic growth, the Natural Killer (NK) Cell Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Natural Killer (NK) Cell Therapeutics market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2018, BisReport analysts believe that in the next few years, Natural Killer (NK) Cell Therapeutics market size will be further expanded, we expect that by 2023, The market size of the Natural Killer (NK) Cell Therapeutics will reach XXX million $.

This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact BisReport

Section 1: Free - Definition

Section (2 3): 1200 USD - Manufacturer Detail
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)

Section 4: 900 USD - Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)

Section (5 6 7): 500 USD -
Product Type Segmentation
Mogamulizumab
Lorvotuzumab Mertansine

Industry Segmentation
Cancer
Cardiovascular Diseases

Channel (Direct Sales, Distributor) Segmentation

Section 8: 400 USD - Trend (2018-2023)

Section 9: 300 USD - Product Type Detail

Section 10: 700 USD - Downstream Consumer

Section 11: 200 USD - Cost Structure

Section 12: 500 USD - Conclusion

SECTION 1 NATURAL KILLER (NK) CELL THERAPEUTICS PRODUCT DEFINITION

SECTION 2 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS MARKET MANUFACTURER SHARE AND MARKET OVERVIEW

2.1 Global Manufacturer Natural Killer (NK) Cell Therapeutics Shipments
2.2 Global Manufacturer Natural Killer (NK) Cell Therapeutics Business Revenue
2.3 Global Natural Killer (NK) Cell Therapeutics Market Overview

SECTION 3 MANUFACTURER NATURAL KILLER (NK) CELL THERAPEUTICS BUSINESS INTRODUCTION

3.1 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Business Introduction
  3.1.1 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Shipments, Price, Revenue and Gross profit 2014-2018
  3.1.2 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Business Distribution by Region
  3.1.3 Chipscreen Biosciences (China) Interview Record
  3.1.4 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Business Profile
  3.1.5 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product Specification
3.2 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Business Introduction
  3.2.1 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Shipments, Price, Revenue and Gross profit 2014-2018
  3.2.2 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Business Distribution by Region
  3.2.3 Interview Record
  3.2.4 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Business Overview
  3.2.5 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product Specification
3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Business Introduction
  3.3.1 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Shipments, Price, Revenue and Gross profit 2014-2018
  3.3.2 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Business Distribution by Region
  3.3.3 Interview Record
  3.3.4 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Business Overview
  3.3.5 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product Specification
3.4 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Business Introduction
3.5 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Business Introduction
3.6 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Business Introduction


SECTION 4 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS MARKET SEGMENTATION (REGION LEVEL)

4.1 North America Country
  4.1.1 United States Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
  4.1.2 Canada Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
4.2 South America Country
  4.2.1 South America Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
4.3 Asia Country
  4.3.1 China Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
  4.3.2 Japan Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
  4.3.3 India Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
  4.3.4 Korea Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
4.4 Europe Country
  4.4.1 Germany Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
  4.4.2 UK Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
  4.4.3 France Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
  4.4.4 Italy Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
  4.4.5 Europe Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
4.5 Other Country and Region
  4.5.1 Middle East Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
  4.5.2 Africa Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
  4.5.3 GCC Natural Killer (NK) Cell Therapeutics Market Size and Price Analysis 2014-2018
4.6 Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Region Level) Analysis 2014-2018
4.7 Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Region Level) Analysis

SECTION 5 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS MARKET SEGMENTATION (PRODUCT TYPE LEVEL)

5.1 Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Product Type Level) Market Size 2014-2018
5.2 Different Natural Killer (NK) Cell Therapeutics Product Type Price 2014-2018
5.3 Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Product Type Level) Analysis

SECTION 6 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS MARKET SEGMENTATION (INDUSTRY LEVEL)

6.1 Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Industry Level) Market Size 2014-2018
6.2 Different Industry Price 2014-2018
6.3 Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Industry Level) Analysis

SECTION 7 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS MARKET SEGMENTATION (CHANNEL LEVEL)

7.1 Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Channel Level) Sales Volume and Share 2014-2018
7.2 Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Channel Level) Analysis

SECTION 8 NATURAL KILLER (NK) CELL THERAPEUTICS MARKET FORECAST 2018-2023

8.1 Natural Killer (NK) Cell Therapeutics Segmentation Market Forecast (Region Level)
8.2 Natural Killer (NK) Cell Therapeutics Segmentation Market Forecast (Product Type Level)
8.3 Natural Killer (NK) Cell Therapeutics Segmentation Market Forecast (Industry Level)
8.4 Natural Killer (NK) Cell Therapeutics Segmentation Market Forecast (Channel Level)

SECTION 9 NATURAL KILLER (NK) CELL THERAPEUTICS SEGMENTATION PRODUCT TYPE

9.1 Mogamulizumab Product Introduction
9.2 Lorvotuzumab Mertansine Product Introduction

SECTION 10 NATURAL KILLER (NK) CELL THERAPEUTICS SEGMENTATION INDUSTRY

10.1 Cancer Clients
10.2 Cardiovascular Diseases Clients

SECTION 11 NATURAL KILLER (NK) CELL THERAPEUTICS COST OF PRODUCTION ANALYSIS

11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview

SECTION 12 CONCLUSION

CHART AND FIGURE

Figure Natural Killer (NK) Cell Therapeutics Product Picture from Chipscreen Biosciences (China)
Chart 2014-2018 Global Manufacturer Natural Killer (NK) Cell Therapeutics Shipments (Units)
Chart 2014-2018 Global Manufacturer Natural Killer (NK) Cell Therapeutics Shipments Share
Chart 2014-2018 Global Manufacturer Natural Killer (NK) Cell Therapeutics Business Revenue (Million USD)
Chart 2014-2018 Global Manufacturer Natural Killer (NK) Cell Therapeutics Business Revenue Share
Chart Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Shipments, Price, Revenue and Gross profit 2014-2018
Chart Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Business Distribution
Chart Chipscreen Biosciences (China) Interview Record (Partly)
Figure Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product Picture
Chart Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Business Profile
Table Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product Specification
Chart Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Shipments, Price, Revenue and Gross profit 2014-2018
Chart Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Business Distribution
Chart Affimed NV (Netherlands) Interview Record (Partly)
Figure Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product Picture
Chart Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Business Overview
Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product Specification
Chart Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Shipments, Price, Revenue and Gross profit 2014-2018
Chart Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Business Distribution
Chart Altor BioScience Corporation (USA) Interview Record (Partly)
Figure Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product Picture
Chart Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Business Overview
Table Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product Specification
3.4 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Business Introduction

Chart United States Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart United States Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart Canada Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Canada Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart South America Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart South America Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart China Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart China Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart Japan Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Japan Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart India Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart India Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart Korea Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Korea Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart Germany Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Germany Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart UK Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart UK Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart France Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart France Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart Italy Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Italy Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart Europe Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Europe Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart Middle East Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Middle East Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart Africa Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Africa Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart GCC Natural Killer (NK) Cell Therapeutics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart GCC Natural Killer (NK) Cell Therapeutics Sales Price ($/Unit) 2014-2018
Chart Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Region Level) Sales Volume 2014-2018
Chart Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Region Level) Market size 2014-2018
Chart Natural Killer (NK) Cell Therapeutics Market Segmentation (Product Type Level) Volume (Units) 2014-2018
Chart Natural Killer (NK) Cell Therapeutics Market Segmentation (Product Type Level) Market Size (Million $) 2014-2018
Chart Different Natural Killer (NK) Cell Therapeutics Product Type Price ($/Unit) 2014-2018
Chart Natural Killer (NK) Cell Therapeutics Market Segmentation (Industry Level) Market Size (Volume) 2014-2018
Chart Natural Killer (NK) Cell Therapeutics Market Segmentation (Industry Level) Market Size (Share) 2014-2018
Chart Natural Killer (NK) Cell Therapeutics Market Segmentation (Industry Level) Market Size (Value) 2014-2018
Chart Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Channel Level) Sales Volume (Units) 2014-2018
Chart Global Natural Killer (NK) Cell Therapeutics Market Segmentation (Channel Level) Share 2014-2018
Chart Natural Killer (NK) Cell Therapeutics Segmentation Market Forecast (Region Level) 2018-2023
Chart Natural Killer (NK) Cell Therapeutics Segmentation Market Forecast (Product Type Level) 2018-2023
Chart Natural Killer (NK) Cell Therapeutics Segmentation Market Forecast (Industry Level) 2018-2023
Chart Natural Killer (NK) Cell Therapeutics Segmentation Market Forecast (Channel Level) 2018-2023
Chart Mogamulizumab Product Figure
Chart Mogamulizumab Product Advantage and Disadvantage Comparison
Chart Lorvotuzumab Mertansine Product Figure
Chart Lorvotuzumab Mertansine Product Advantage and Disadvantage Comparison
Chart Cancer Clients
Chart Cardiovascular Diseases Clients


More Publications